Clinical Trials
Clinical trials are research studies that help doctors find ways to improve health care. Each study attempts to address scientific questions and to find better methods of preventing, diagnosing, or treating disease. To learn more about clinical trials currently being conducted in the Scott Department of Urology, please choose from the links below.
Bladder Cancer
Tamoxifen for Progressive Transitional Cell Cancer Following Previous Chemotherapy
Drs. Seth P. Lerner, Gilad E. Amiel, Guru P. Sonpavde, and Garrett R. Lynch
[Protocol H-16848]
Screening for Bladder Cancer
Drs. Seth P. Lerner and Gilad E. Amiel
[Protocol H-20395]
Gemcitabine in Treating Patients with Recurrent Bladder Cancer That Has Not Responded to Previous BCG
Drs. Seth P. Lerner and Gilad E. Amiel
[Protocol H-20821]
Gemcitabine After Surgery in Treating Patients with Newly Diagnosed or Recurrent Bladder Cancer
Drs. Seth P. Lerner and Gilad E. Amiel
[Protocol H-21652]
Bladder Cancer Imaging Study - OCT Imaging to Stage Bladder Tumors
Drs. Seth P. Lerner and Gilad E. Amiel
[Protocol H-21830]
Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients with Advanced Urothelial Cancer
Drs. Seth P. Lerner, Gilad E. Amiel, and Guru P. Sonpavde
[Protocol H-22935]
Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Cancer of the Bladder
Drs. Seth P. Lerner, Gilad E. Amiel, and Guru P. Sonpavde
[Protocol H-22995]
Genetic Susceptibility to Bladder Cancer
Dr. Seth P. Lerner and Gilad E. Amiel
[Protocol H-8577]
Evaluation of Sexual Dysfunction in Bladder Cancer Patients and Their Partners
Dr. Gilad E. Amiel
[Protocol H-20192]
Kidney Cancer
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
Drs. Seth P. Lerner, Gilad E. Amiel, Guru P. Sonpavde, Garrett R. Lynch, and Richard E. Link
[Protocol H-19727]
Genetic Susceptibility to Kidney Cancer
Drs. Seth P. Lerner, Gilad E. Amiel, and Richard E. Link
[Protocol H-17150]
Prostate Cancer
Docetaxel and Prednisone with or without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
Drs. Seth P. Lerner, Gilad E. Amiel, Guru P. Sonpavde, and Garrett R. Lynch
[Protocol H-20457]
Testosterone for Penile Rehab After Radical Prostatectomy
Drs. Mohit Khera and Larry I. Lipshultz
[NCT00848497]
Men's Health
BOTOX® for Peyronie's Disease
Drs. Mohit Khera and Larry I. Lipshultz
[Protocol H-22411; NCT00812838]
For more research clinical trials currently being conducted in the Scott Department of Urology, please see Studies - Urology Health Research. For general information regarding clinical trials, please see the National Cancer Institute or the NIH Clinical Trials web sites.